Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Courtney Johnson, Jennifer Stephens, Christopher Walker, Joseph C Cappelleri & Ahmed Shelbaya. (2020) Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis. ClinicoEconomics and Outcomes Research 12, pages 57-67.
Read now
Read now
Ahmed Shelbaya, Caitlyn T Solem, Chris Walker, Yin Wan, Courtney Johnson & Joseph C Cappelleri. (2018) The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis. ClinicoEconomics and Outcomes Research 10, pages 213-222.
Read now
Read now
Yanzhi Liu, Yang Cui, Yan Chen, Xiang Gao, Yanjie Su & Liao Cui. (2015) Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats. Clinical Interventions in Aging 10, pages 1245-1253.
Read now
Read now
Articles from other publishers (6)
Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022)
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
—
United States, 2022
. MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Crossref
Jiayu Shi, Kenan Fan, Lei Yan, Zijuan Fan, Fei Li, Guishan Wang, Haifeng Liu, Peidong Liu, Hongmei Yu, Jiao Jiao Li & Bin Wang. (2022) Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review. Applied Health Economics and Health Policy 20:3, pages 351-370.
Crossref
Crossref
Margaret N. Essex, Michael A. O'Connell, Regina Behar & Weihang Bao. (2015) Efficacy and safety of nonsteroidal anti‐inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo‐controlled study. International Journal of Rheumatic Diseases 19:3, pages 262-270.
Crossref
Crossref
Chao Zeng, Jie Wei, Hui Li, Tuo Yang, Shu-guang Gao, Yu-sheng Li, Yi-lin Xiong, Wen-feng Xiao, Wei Luo, Tu-bao Yang & Guang-hua Lei. (2015) Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis. Scientific Reports 5:1.
Crossref
Crossref
Nadir Hammoumraoui, Sid Ahmed Kherraf, Joaquin Mould-Quevedo & Tarek A. Ismail. (2013) The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria. Journal of Health Economics and Outcomes Research 1:2, pages 184-199.
Crossref
Crossref
Krysia Dziedzic. (2013) Recent advances in the diagnosis and management of hand osteoarthritis. International Journal of Clinical Rheumatology 8:4, pages 439-452.
Crossref
Crossref